Taylor Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$673K Hold
1,740
0.37% 60
2026
Q1
$509K Sell
1,740
-125
-7% -$41.1K 0.31% 65
2025
Q4
$654K Hold
1,865
0.38% 53
2025
Q3
$603K Hold
1,865
0.35% 54
2025
Q2
$725K Hold
1,865
0.45% 46
2025
Q1
$811K Sell
1,865
-100
-5% -$40.1K 0.56% 41
2024
Q4
$725K Hold
1,965
0.5% 42
2024
Q3
$1.02M Sell
1,965
-100
-5% -$53.4K 0.71% 36
2024
Q2
$1.12M Hold
2,065
0.86% 30
2024
Q1
$1.07M Hold
2,065
0.82% 31
2023
Q4
$974K Buy
+2,065
New +$955K 0.8% 33

Other funds holding ELV

Taylor Financial Group's ELV Position: Q2 2026 in Review

Taylor Financial Group held its Elevance Health (ELV) position steady in Q2 2026 at 1,740 shares worth $673K. The position accounts for 0.37% of the portfolio, ranked #60.

Taylor Financial Group first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.12M in Q2 2024. 615 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Taylor Financial Group held 1,740 shares of Elevance Health worth $673K as of Q2 2026.
  • Taylor Financial Group left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.37% of Taylor Financial Group's portfolio in Q2 2026, its #60 holding.
  • Taylor Financial Group first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Taylor Financial Group's Elevance Health position peaked at $1.12M in Q2 2024.
  • 615 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Taylor Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.